Is a novel I214M substitution in the NEFL gene a cause of Charcot‐Marie‐Tooth disease? Functional analysis using cell culture models

D Kabzińska, R Perez‐Olle, D Goryunov… - Journal of the …, 2006 - Wiley Online Library
D Kabzińska, R Perez‐Olle, D Goryunov, H Drac, B Ryniewicz, I Hausmanowa‐Petrusewicz…
Journal of the Peripheral Nervous System, 2006Wiley Online Library
Recent studies have shown that mutations in neurofilament light subunit gene (NEFL) cause
Charcot‐Marie‐Tooth (CMT) disease. Since the first description of the Gln333Pro mutation in
the NEFL gene, 10 pathogenic mutations in the NEFL gene have been reported in patients
affected with CMT disease. We report a novel I214M amino acid substitution in the NEFL
gene in two unrelated patients affected with CMT. Because the I214M amino acid
substitution in the NEFL protein was not detected in a CMT affected brother of the proband …
Abstract
Recent studies have shown that mutations in neurofilament light subunit gene (NEFL) cause Charcot‐Marie‐Tooth (CMT) disease. Since the first description of the Gln333Pro mutation in the NEFL gene, 10 pathogenic mutations in the NEFL gene have been reported in patients affected with CMT disease. We report a novel I214M amino acid substitution in the NEFL gene in two unrelated patients affected with CMT. Because the I214M amino acid substitution in the NEFL protein was not detected in a CMT affected brother of the proband, its pathogenic effect became unclear. In order to determine whether this amino acid substitution is a benign polymorphism or causative of the disease, we performed a functional analysis of the mutant I214M neurofilament protein (NFL). Transfections of the mutant protein in cultured cells revealed an increased tendency to form highly compacted filamentous structures but no other alterations of neurofilament assembly or transport were observed. Furthermore, the sibling of one of the patients was also affected with CMT but did not have the I214M substitution. These data suggest that this I214M substitution in the NEFL gene was not a direct cause of the disease but could be a polymorphism or possibly a modifier of the CMT phenotype.
Wiley Online Library